Page 14 - Rna News Today

In this eighth episode of OncChats: Assessing the Promise of AI in Oncology, Toufic A. Kachaamy, MD, and Douglas Flora, MD, LSSBB, FACCC, explain how artificial intelligence tools are being developed to match the right patient to the right drug on the right clinical trial.

In response to a letter in which Florida Surgeon General Joseph Ladapo noted the detection of DNA fragments in mRNA COVID-19 vaccines, Peter Marks, director of the U.S. Food and Drug Administration's Center for Biologics Evaluation and Research, emphasized the FDA's view that the shots are safe and effective.

Look into the process of COVID mRNA shot approval

Mirador Capital Partners LP decreased its holdings in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 76.5% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 16,366 shares of the biotechnology company’s stock after selling 53,395 shares during the period. Mirador Capital […]

BARCELONA, Spain & NIEL, Belgium, December 12, 2023--Almirall, S.A. (ALM), a global pharmaceutical company focused on medical dermatology, and etherna, an mRNA/LNP technology platform company, announced today a multi-target alliance to discover and develop new mRNA-based therapies for severe skin diseases, including non-melanoma skin cancer.

From COVID-19 vaccines to cancer treatments and beyond, the flexibility of mRNA-based therapies gives them the potential to prevent and treat many types of diseases.

From COVID-19 vaccines to cancer treatments and beyond, the flexibility of mRNA-based therapies gives them the potential to prevent and treat many types of diseases.

Just 8.5% of eligible patients were screened for hepatitis C - among them, 5.9% tested positive for HCV antibody and 3.0% had an active infection.

Government officials are making efforts to reduce supervision requirements for certified registered nurse anesthetists in 2023.

A peer-reviewed University of Cambridge study published Wednesday in the scientific journal Nature has revealed the Nobel Prize-winning technique that paved the way for synthetic messenger ribonucleic acid vaccines is far from flawless. To trick the body into allowing cellular interventions by...